This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 45 and 60
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

RATIONALE: Patient abstract not available PURPOSE: Patient abstract not available

Provided treatments

  • Biological: sargramostim
  • Drug: amsacrine
  • Drug: cytarabine
  • Drug: daunorubicin hydrochloride
  • Procedure: quality-of-life assessment

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01324063. The sponsor of the trial is European Organisation for Research and Treatment of Cancer - EORTC and it is looking for 160 volunteers for the current phase.
Official trial title:
A Randomized Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogenous Leukemia (AML-8B)